News · PR

  • HOME
  • News · PR
  • Bushu Pharmaceuticals Ltd. Appoints New Vice President/Chief Operating Officer

News · PR

Bushu Pharmaceuticals Ltd. Appoints New Vice President/Chief Operating Officer

  • News

July 1st , 2019 – Bushu Pharmaceuticals Ltd. (Kawagoe, Saitama, Japan, Representative Director, President and CEO: Jun Yokohama) today named Mr. Tadao Takano to be the Vice President/Chief Operating Officer.
He has mighty knowledge and experiences about pharmaceutical market, small-molecule drug and biopharmaceuticals in order for Bushu Pharmaceuticals Ltd. to meet herculean requirements from pharmaceutical makers which are challenging their dynamic changing business field. You may find the career of Mr. Takano as bellow. Mr. Tadao Takano
Wyeth KK, Material Manager
Takeda Bio Development Center Ltd. (former name Amgen KK) Director, Clinical Trial Material Management & Technical Support
Shire Japan KK, Head of Supply Chain JAPAC
Amgen Astellas Biopharma KK Senior Manager Supply Chain
Alnylam Japan KK Director, Head of Supply Chain For further information, please contact
Makoto Sekine, Marketing division
Phone:+81-0490273-6386  Email:
Address: 1 Takeno, Kawagoe, Saitama, 3500801, Japan About us
Bushu Pharmaceuticals Ltd. was established in August 1998 as an independent pharmaceutical contract manufacturer. Bushu has capital of 1 billion yen. Bushu carries out contract manufacturing and packaging of clinical trials and commercial products in accordance with latest GMP standards. Through the utilization of know-how and latest industry information, Bushu prides itself in being able to offer added-value solutions to customers. For more information,
refer to our website:


As a company specializing in contract manufacturing of pharmaceutical drugs, we offer a wide range of contract services tailored to clients’ needs based on our extensive experience and know-how accumulated over many years.